Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
The right treatment depends on a patients BMI, medical history, current medicines, side effect risk and clinical assessment
In people with T2D, retatrutide (0.5 to 12 mg) led to substantial reductions in bodyweight and HbA1c compared to both placebo and dulaglutide 1.5 mg in a phase 2 trial [67]
Learn more about required labs for weight management
Mounjaro Market Size and Forecast 2025 to 2034 The global mounjaro market size accounted for USD 14.18 billion in 2024 and is predicted to increase from USD 16.82 billion in 2025 to approximately USD 78.51 billion by 2034, expanding at a CAGR of 18.67% from 2025 to 2034
US$ 27.67
US$ 24.26
US$ 20.88
US$ 28.29
.png)
US$ 22.38
